"Don't be in such a hurry to get back to them. ”

On the phone call to Han Jia, Tian Lu hesitated for a moment and said in a low voice: "Aren't the brokers evaluating us now? ”

"Okay. ”

Han Jia understood what Tian Lu meant when she heard it, and immediately agreed.

For Olge's idea of wanting to take a stake in Lantian Company, neither Tian Lu nor Han Jia is very repulsive, after all, although the other party is not the top in the world, but it is still a member of the multinational giants, if it can occupy a stake in Lantian Company, it will definitely be able to give some help in terms of sales channels in the future. But in the same way, neither of them will transfer the shares when they don't know the true value of Lantian Company!

It is true that although the sales of Lantian Company are not low, it basically relies on the prestige of Tianlu and the performance of its products, the scale of the company is not large, and the overall strength is not very strong because of time, but this does not mean that its value can be assessed by virtue of total assets and other things.

As long as you calculate the hundreds of patents that Tianlu has invested in the past few years and the next period of time, you will understand that the future of Lantian Company is limitless!

So although it was decided that he would definitely need financing to get funds, Tian Lu was not in a hurry.

In fact, Han Jia is not particularly anxious。。。。。。

。。。。。。

After settling in the new scientific research base, Future Biology has finally ushered in a period of concentrated outbreak!

In just half a year, more than 100 scientific research achievements of all sizes have been successfully released. It is either published in Tian Lu's own magazine, which continues to increase the influence of the magazine, or published in other top foreign journals according to the wishes of all members of the research group. But no matter where it is published, the name Future Biotech has become more and more famous all over the world!

As for the patent research and development, which is still the focus, there are also seven or eight patents, but there is only one heavyweight patent: sedative drugs!

This is also one of the most sold drugs in the world!

There is no doubt that the most important thing about sedative drugs is their effectiveness and safety, and Tian Lu selected the one with the best performance from several best-selling sedative drugs in the future, and it was natural that it was once it was launched. It has attracted the attention of many pharmaceutical giants!

Although the first few patented drugs have been marketed. And to bring huge profits to Future Biotech and the giants who bought patents, all pharmaceutical companies have understood one thing, that is, as long as the patents developed by Future Biotech are almost certainly able to be marketed eventually. And it will inevitably become one of the new bombshells! And what is even more difficult to ignore is. Whether it is the efficacy or safety of the drug. Future Biotech's products are almost all outstanding!

That is to say, as long as the company has sufficient marketing capabilities, relying on the patented technology of Future Biotech. It's only a matter of time before you take the biggest market share!

What multinational giant doesn't want such a patent?

Therefore, after learning that Future Biotech has a new patent, various giants who have cooperated with Future Biotech, or regret it because they have not cooperated, have called, and even many have directly sent people to Kyoto to explore the bidding process for new patents.

It's just that after thinking about it for a long time, Tian Lu gave an order, and the new drug was put into the laboratory that had just digested the drug R&D department of Kyoto Pharmaceutical Group, and it was also determined that the new drug would be handed over to Kyoto Pharmaceutical for follow-up clinical trials and marketing!

This result naturally makes many multinational giants quite dissatisfied.

"You don't need to pay attention to this kind of complaint!"

When Qian Lele called with some anxiety, Tian Lu replied casually: "The patent is developed by Future Biotech, and we have the right to dispose of it at will, and no one has any reason to interfere!" Tell them that if there is a patent that needs to be sold by bidding in the future, we will notify them in advance!"

"Ugh。。。。。。 All right. ”

Although he also knew that there was no need to care about the current future creatures, Qian Lele still couldn't turn the corner for a while, and when he heard Tian Lu say this, he suddenly felt relieved.

No matter what time it is, as long as the words that come out of Tian Lu's mouth are always the most reassuring.

Putting down the big stone in his heart, Qian Lele turned to smile and said: "By the way, are you free this weekend? The weather is too hot, make an appointment with Feng Lin and them to swim at your house。。。。。。。 ”

The summer of 2026 came early, and the momentum was fierce and abnormal!

Just entered July, there have been several days of more than 35 degrees of high temperature, and the swimming pool in Tian Lu's villa is naturally very popular with everyone, Tian Huan and Tian Le have to go down to swim a few laps every day, even the little guy of Feng Lin's family is also shouting every day to come over to play, even the adults, now the party has chosen to be at home, not very willing to go out.

In addition to the hot weather, there are many people's minds.

In the president's office of Kyoto Pharmaceutical, the busy Meng Yun welcomed two very important guests.

"Mr. Meng, now we are more and more unable to understand the development of Kyoto Medicine!"

A middle-aged woman in a white professional skirt frowned and said sharply: "We are investors, we chose to invest in Kyoto Medicine because we were optimistic about its profitability and development speed, and the pursuit of profit is our ultimate goal。。。。。。! It's hard for us to accept!"

After hearing the middle-aged woman's words, another man in his fifties also nodded frequently in agreement.

The two are representatives of the other two shareholders of Kyoto Pharmaceutical Group, and they came to Meng Yun today because they had just passed on the news that Future Biology will continue to inject capital into Kyoto Pharmaceutical with a patent for a sedative drug, and further expand their shares!

This news made both companies not calm.

In the past three years. Future Biotech's shareholding in Kyoto Pharmaceutical has been close to 80%, and the shares of the two investment companies, which were originally relatively large, have now dropped sharply to about 7%!

This number has no right to speak!

You must know that Kyoto Pharmaceutical was still a pure state-owned enterprise at the beginning, and the two investment companies were optimistic about the profitability of the company, so they invested a sum of money accounting for 30% of the shares, but because of the strength of the state-owned shares at that time, it was stipulated that they only had the right to dividends and no decision-making power!

That's why neither company can stop Future Biotech from continuing to expand its stake!

As a matter of fact. If the investment of Future Biotech can make Kyoto Pharmaceutical continue to make profits. Of course, the two investment companies have nothing to say, but the key is that the acquisition of Future Biotech not only did not improve Kyoto Pharmaceutical's profit figures, but made it start to lose money every year!

Most of the low-value drug lines and brands were sold or cut off. Streamlining the relevant sales department. Instead, focus on the follow-up development of new drug patents. This made Kyoto Pharmaceutical, which had been profitable every year, lose money last year to a peak!

700 million Chinese dollars!

This result is really difficult for the two companies to accept!

Yes, anyone with a discerning eye can see the ambition of Kyoto Medicine, and they can also understand that as long as they can stick to it. It will take up to five years for Kyoto Pharmaceutical to turn a profit. Moreover, the patents injected by the future bio are not only those blockbuster drugs, but also some cutting-edge products with a small market scale but relatively weak competition, which can not only improve the company's product line, but also produce a lot of economic benefits!

If the two are the kind of investment companies with strong strength, they naturally don't mind putting a long line to catch big fish, but both are small domestic investment companies with limited assets, and if you have to wait so long, I'm afraid it will be a little unbearable.

"Let me tell you that!"

The man put his hands together and said helplessly: "Our company's capital situation in the past two years is not very good, so we urgently need to replenish liquidity, so if Kyoto Pharmaceutical can't give enough dividends in the next three years, I'm afraid we can only give up waiting!"

"So do we!"

The middle-aged woman's eyes flashed, and she also echoed casually.

"Give up?"

Meng Yun was a little amused in his heart, and raised his eyebrows and asked, "Do you mean to quit Kyoto Medicine?"

As the president of Kyoto Pharmaceutical, Meng Yun certainly has a reason to ask.

In the past few years, every time he thinks of the future of Kyoto Medicine, Meng Yun can't help but tremble, he knows that as long as Future Biotech can maintain such investment, the first real multinational pharmaceutical giant in China will definitely be born in his own hands!

Meng Yun believes that the two investment companies will not fail to see this!

It's just that for Meng Yun's words, after the two representatives of the investment company glanced at each other, they shook their heads at the same time, and the middle-aged woman said in a low voice: "Mr. Meng, we understand what you mean very well, but in fact, it is really difficult for us to survive, and the shareholders of the company do not want the future, but the present! So I'm sorry。。。。。。 ”

After being stunned for a while, a trace of doubt flashed in Meng Yun's eyes, and he shook his head and said, "Then I can answer you now with certainty, it is impossible to make a profit in the next five years, and the possibility of continuous losses is very high!"

"Then we want to be able to activate the terms we signed when we first bought the shares!"

Almost as soon as Meng Yun's words fell, the middle-aged woman immediately said, "Please allow us to transfer all the shares by ourselves!"

"Transfer the shares yourself?

After hearing the middle-aged woman's words, Meng Yun's brows furrowed, and he immediately shouted categorically!

"Why not?"

The two people on the opposite side were not annoyed, and quietly glared at the anxious middle-aged woman, and the man said slowly: "Mr. Meng, we have already had an agreement, and Kyoto Medicine has no right to prevent us from transferring our shares!"

Discovering the eyebrow teleportation between the two, Meng Yun instantly understood!

And at this moment, Meng Yun was almost certain of one thing, there was no profit, and continuous losses were not the reason, I am afraid that the transfer of this share is the real purpose!

Meng Yun didn't know who the other party wanted to transfer these shares to, but the fire in his heart couldn't be suppressed at this time!

However, no matter how angry he was, Meng Yun didn't show it on his face, but became more and more calm, shook his head and said: "Yes, there is such a clause, if the company continues to lose money and is unwilling to accept your opinions for rectification, you can withdraw." But again, I know that there is another clause, which is that even if you want to transfer your shares, Kyoto Pharmaceutical has absolute priority! At the same time, don't forget, what is the meaning of the so-called priority, but it is not that we have to pay how much money others pay, I once calculated, at the beginning Kyoto Pharmaceutical was still a small business, you were a 1.2 billion Chinese dollars in the shares, accounting for 30% of the shares, now, although the value of the future biology is high, but we may only need 8 billion Chinese dollars at most to complete the acquisition!"

"The question is, can Kyoto Medicine come up with this 10 billion now?"

Obviously, both of them came prepared, and the middle-aged woman Shi Shiran asked with a smile. The current situation of Kyoto Pharmaceutical is very clear to the two shareholders, although the future biology has invested a lot of money, but on the one hand, the drastic restructuring costs a lot, on the other hand, the follow-up research and development of a variety of new products also costs a lot, not to mention eight billion Chinese dollars, I am afraid that four billion Meng Yun will not be able to come up!

"You don't have to worry about that!"

The expression on Meng Yun's face was calm and chilling, and he waved his hand and sneered: "You only need to submit an application for withdrawal of shares, whether we can take out this money or not, you will know soon。。。。。。 (To be continued.) )